@berad “Little knowledge is more dangerous “. I would assume...

@berad “Little knowledge is more dangerous “. I would assume that other company you referring is CYP. Firstly, its not partnered. Fujifilm has got stake worth $3 millions and they have an “option” to proceed further and burn trial cost. Secondly, your claim about that being more effective is based on the preliminary results. Its too early to judge as for 2 years without intervention they need to see its efficacy and safety profile-long miles to go.
MSB is the leader in the regenerative medicine. Period!!